To develop probiotics for Helicobacter pylori infection, we screened 203 Latobacillus strains. Lactobacillus gasseri OLL2716 (LG21) was selected as the most effective strain to inhibit the growth of H. pylori by in vitro tests and animal study. We examined the effects of yogurt containing LG21 on H. pylori infection in humans. The intake of yogurt containing LG21 both decreases the number of H. pylori and also reduces mucosal inflammation.
INTRODUCTION
The evidence of a relationship between Helicobacter pylori and gastric diseases has gradually become clear since Warren and Marshall succeeded in cultivating this bacterium in 1982. Since the infection rate of H. pylori is very high, about 50% in Japanese, it is difficult to eradicate H. pylori in all people infected. The eradication therapy using antibiotics is often accompanied by side effects and not always successful because of antibiotic-resistant strains.
We found that orally administered lactobacilli could eradicate H. pylori in a gnotobiotic murine model (1, 6 ). So we screened 203 Latobacillus strains to select a strain that exhibited excellent anti-H. pylori activity in vitro and in animal studies, and selected Lactobacillus gasseri OLL2716 (LG21) as the most suitable strain for use as a probiotic for H. pylori infection.
We also examined the efficacy of LG21 against H.
pylori infection in humans.
HELICOBACTER PYLORI
H. pylori is a spiral Gram-negative rod with unipolar flagella. This bacterium inhabits the human stomach and can cause chronic inflammation and ulcers of the stomach and duodenum. H. pylori has also been identified as a risk factor for stomach cancer. H. pylori has strong urease and can catalyze urea in the stomach to ammonia and carbon dioxide. H. pylori can survive under strong acidic conditions because of this ammonia production.
Selection of anti-H. pylori lactic acid bacteria in vitro
To select an anti-H. pylori lactic acid bacteria, anti-H. pylori abilities (resistance to artificial gastric juice, proliferation under acidic conditions, adherence to cultured gastric epithelial cells, suppression of H. pylori during co-fermentation and survival in yogurt) of 203 Lactobacillus strains were examined in vitro. Lactobacillus gasseri OLL2716 (LG21), Lactobacillus gasseri No. 6 and Lactobacillus salivarius WB 1004 were selected as lactic acid bacteria with excellent anti-H. pylori properties (data not shown).
ANIMAL STUDY
Following in vitro experiments, the effects of the administration of Lactobacillus strains (LG21, L. gasseri No. 6, L. salivarius WB1004) on H. pylori-infected mice were examined. For H. pylori infection, 109 cfu of H. pylori were orally administered to germfree mice once a day for 3 days. Six weeks after the administration of H. pylori, 109 cfu of Lactobacillus strains were administered once a week for 8 weeks. One week after finishing the administration of Lactobacillus strains, the number of H. pylori and serum anti-H.
pylori IgG levels were measured.
No H. pylori was detected in the mice administered LG21 and L. salivarius WB 1004, and the anti-H. pylori IgG levels of the mice administered LG21 were the lowest (Fig. 1) Fig. 3 . Effect of yogurt containing LG21 on serum pepsinogen I/ II ratio of subjects infected with H. pylori. 
